Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T34429 | Target Info | |||
Target Name | Neuronal acetylcholine receptor alpha-7 (CHRNA7) | ||||
Synonyms |
Nicotinic acetylcholine receptor subunit alpha 7; Nicotinic acetylcholine receptor alpha7; CHRNA7; Alpha7 nicotinic receptor; Alpha7 nAChR; Alpha-7 nAChR; Alpha(7) nicotinic receptor
Click to Show/Hide
|
||||
Target Type | Successful Target | ||||
Gene Name | CHRNA7 | ||||
Biochemical Class | Neurotransmitter receptor | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | 5-HT 2A receptor (HTR2A) | Successful Target | ||||
UniProt ID | 5HT2A_HUMAN | |||||
Gene Name | HTR2A | |||||
Synonyms |
Serotonin receptor 2A; HTR2; 5-hydroxytryptamine receptor 2A; 5-HT-2A; 5-HT-2
Click to Show/Hide
|
|||||
Representative Drug(s) | Ziprasidone | Drug Info | Ki = 0.08 nM | [1] | ||
Co-Target Name | Neuronal acetylcholine receptor alpha-4/beta-2 (CHRNA4/B2) | Successful Target | ||||
UniProt ID | ACHA4_HUMAN-ACHB2_HUMAN | |||||
Gene Name | CHRNA4-CHRNB2 | |||||
Synonyms |
CHRN; nAChR
Click to Show/Hide
|
|||||
Representative Drug(s) | CYTISINE | Drug Info | Ki = 0.23 nM | Click to Show More | [2] | |
2 | GTS-21 | Drug Info | Ki = 51 nM | [8] | ||
Co-Target Name | 5-HT 2C receptor (HTR2C) | Successful Target | ||||
UniProt ID | 5HT2C_HUMAN | |||||
Gene Name | HTR2C | |||||
Synonyms |
Serotonin receptor 2C; HTR1C; 5HT-1C; 5-hydroxytryptamine receptor 2C; 5-hydroxytryptamine receptor 1C; 5-HTR2C; 5-HT2C receptor; 5-HT2C; 5-HT1C; 5-HT-2C; 5-HT-1C
Click to Show/Hide
|
|||||
Representative Drug(s) | Ziprasidone | Drug Info | Ki = 0.55 nM | [3] | ||
Co-Target Name | Dopamine D2 receptor (D2R) | Successful Target | ||||
UniProt ID | DRD2_HUMAN | |||||
Gene Name | DRD2 | |||||
Synonyms |
Dopamine receptor 2; D(2) dopamine receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | Ziprasidone | Drug Info | Ki = 0.8 nM | [4] | ||
Co-Target Name | 5-HT 1A receptor (HTR1A) | Successful Target | ||||
UniProt ID | 5HT1A_HUMAN | |||||
Gene Name | HTR1A | |||||
Synonyms |
Serotonin receptor 1A; G-21; ADRBRL1; ADRB2RL1; 5-hydroxytryptamine receptor 1A; 5-HT1A receptor; 5-HT1A; 5-HT-1A
Click to Show/Hide
|
|||||
Representative Drug(s) | Ziprasidone | Drug Info | Ki = 1.585 nM | [5] | ||
Co-Target Name | 5-HT 2B receptor (HTR2B) | Successful Target | ||||
UniProt ID | 5HT2B_HUMAN | |||||
Gene Name | HTR2B | |||||
Synonyms |
Serotonin receptor 2B; 5-hydroxytryptamine receptor 2B; 5-HT2B; 5-HT-2B; 5-HT 2B
Click to Show/Hide
|
|||||
Representative Drug(s) | Ziprasidone | Drug Info | Ki = 1.585 nM | [5] | ||
Co-Target Name | Histamine H1 receptor (H1R) | Successful Target | ||||
UniProt ID | HRH1_HUMAN | |||||
Gene Name | HRH1 | |||||
Synonyms |
HH1R; H1R
Click to Show/Hide
|
|||||
Representative Drug(s) | Ziprasidone | Drug Info | Ki = 5.3 nM | [6] | ||
Co-Target Name | Dopamine D3 receptor (D3R) | Successful Target | ||||
UniProt ID | DRD3_HUMAN | |||||
Gene Name | DRD3 | |||||
Synonyms |
D(3) dopamine receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | Ziprasidone | Drug Info | Ki = 6.31 nM | [5] | ||
Co-Target Name | Dopamine D1 receptor (D1R) | Successful Target | ||||
UniProt ID | DRD1_HUMAN | |||||
Gene Name | DRD1 | |||||
Synonyms |
D(1A) dopamine receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | Ziprasidone | Drug Info | Ki = 9.5 nM | [3] | ||
Co-Target Name | Dopamine D4 receptor (D4R) | Successful Target | ||||
UniProt ID | DRD4_HUMAN | |||||
Gene Name | DRD4 | |||||
Synonyms |
DRD4; D(2C)D(4) dopamine receptor dopamine receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | Ziprasidone | Drug Info | Ki = 32 nM | [7] | ||
Co-Target Name | Serotonin transporter (SERT) | Successful Target | ||||
UniProt ID | SC6A4_HUMAN | |||||
Gene Name | SLC6A4 | |||||
Synonyms |
Solute carrier family 6 member 4; HTT; 5HTT; 5HT transporter
Click to Show/Hide
|
|||||
Representative Drug(s) | Ziprasidone | Drug Info | Ki = 53 nM | [7] | ||
Co-Target Name | Voltage-gated potassium channel Kv11.1 (KCNH2) | Successful Target | ||||
UniProt ID | KCNH2_HUMAN | |||||
Gene Name | KCNH2 | |||||
Synonyms |
hERG1; hERG-1; Voltage-gated potassium channel subunit Kv11.1; Potassium voltage-gated channel subfamily H member 2; HERG K+ channel; HERG; H-ERG; Ether-a-go-go-related protein 1; Ether-a-go-go-related gene potassium channel 1; Ether-a-go-go related protein 1; Ether-a-go-go related gene potassium channel 1; Eag related protein 1; Eag homolog; ERG-1; ERG
Click to Show/Hide
|
|||||
Representative Drug(s) | Ziprasidone | Drug Info | IC50 = 120.23 nM | [9] | ||
Co-Target Name | Neuronal acetylcholine receptor alpha-3/beta-4 (CHRNA3/B4) | Successful Target | ||||
UniProt ID | ACHA3_HUMAN-ACHB4_HUMAN | |||||
Gene Name | CHRNA3-CHRNB4 | |||||
Synonyms |
Neuronal acetylcholine receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | CYTISINE | Drug Info | Ki = 280 nM | [10] | ||
Co-Target Name | 5-HT 3A receptor (HTR3A) | Successful Target | ||||
UniProt ID | 5HT3A_HUMAN | |||||
Gene Name | HTR3A | |||||
Synonyms |
Serotonin-gated ion channel receptor; Serotonin receptor 3A; HTR3; 5HT3R; 5-hydroxytryptamine receptor 3A; 5-HT3RA; 5-HT3A; 5-HT3-A; 5-HT 3A
Click to Show/Hide
|
|||||
Representative Drug(s) | EVP-6124 | Drug Info | IC50 = 299 nM | [11] | ||
Co-Target Name | Adrenergic receptor Alpha-2 (ADRA2) | Successful Target | ||||
UniProt ID | ADA2A_HUMAN; ADA2B_HUMAN; ADA2C_HUMAN | |||||
Gene Name | NO-GeName | |||||
Synonyms |
Alpha-2 adrenergic receptor; Alpha(2)-adrenoceptor
Click to Show/Hide
|
|||||
Representative Drug(s) | Ziprasidone | Drug Info | Ki = 390 nM | Click to Show More | [3] | |
2 | Ziprasidone | Drug Info | Ki = 390 nM | [3] | ||
Co-Target Name | 5-HT 3 receptor (5HT3R) | Successful Target | ||||
UniProt ID | 5HT3A_HUMAN; 5HT3B_HUMAN; 5HT3C_HUMAN; 5HT3D_HUMAN; 5HT3E_HUMAN | |||||
Gene Name | NO-GeName | |||||
Synonyms |
5-hydroxytryptamine receptor type 3; 5-hydroxytryptamine receptor 3; 5-HT3R; 5-HT3 receptor; 5-HT-3
Click to Show/Hide
|
|||||
Representative Drug(s) | Ziprasidone | Drug Info | Ki = 398.11 nM | [5] | ||
Co-Target Name | 5-HT 7 receptor (HTR7) | Clinical trial Target | ||||
UniProt ID | 5HT7R_HUMAN | |||||
Gene Name | HTR7 | |||||
Synonyms |
Serotonin receptor 7; 5HT7; 5-hydroxytryptamine receptor 7; 5-HT7 receptor; 5-HT7; 5-HT-X; 5-HT-7
Click to Show/Hide
|
|||||
Representative Drug(s) | Ziprasidone | Drug Info | Ki = 5 nM | [4] | ||
Co-Target Name | 5-HT 6 receptor (HTR6) | Clinical trial Target | ||||
UniProt ID | 5HT6R_HUMAN | |||||
Gene Name | HTR6 | |||||
Synonyms |
Serotonin receptor 6; 5-hydroxytryptamine receptor 6; 5-HT6 receptor; 5-HT6; 5-HT-6
Click to Show/Hide
|
|||||
Representative Drug(s) | Ziprasidone | Drug Info | Ki = 20 nM | [4] | ||
Co-Target Name | HUAMN alpha-1 adrenergic receptor (ADRA1) | Literature-reported Target | ||||
UniProt ID | ADA1A_HUMAN; ADA1B_HUMAN; ADA1D_HUMAN | |||||
Gene Name | ADRA1A; ADRA1B; ADRA1D | |||||
Synonyms |
Alpha-1 adrenoreceptor
Click to Show/Hide
|
|||||
Representative Drug(s) | Ziprasidone | Drug Info | Ki = 1.9 nM | [3] | ||
Co-Target Name | Acetylcholine receptor alpha-1/beta-1/delta/gamma (CHRNA1/CHRNA1/CHRND/CHRNG) | Co-Target | ||||
UniProt ID | ACHA_HUMAN-ACHB_HUMAN-ACHD_HUMAN-ACHG_HUMAN | |||||
Gene Name | CHRNA1-CHRNB1-CHRND-CHRNG | |||||
Representative Drug(s) | CYTISINE | Drug Info | EC50 = 11 nM | [12] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | 1-Aminoindanes as novel motif with potential atypical antipsychotic properties. Bioorg Med Chem Lett. 2008 Jan 15;18(2):489-93. | ||||
REF 2 | 3,5-Bicyclic aryl piperidines: a novel class of alpha4beta2 neuronal nicotinic receptor partial agonists for smoking cessation. Bioorg Med Chem Lett. 2005 Nov 15;15(22):4889-97. | ||||
REF 3 | Current and novel approaches to the drug treatment of schizophrenia. J Med Chem. 2001 Feb 15;44(4):477-501. | ||||
REF 4 | Novel multi-target azinesulfonamides of cyclic amine derivatives as potential antipsychotics with pro-social and pro-cognitive effects. Eur J Med Chem. 2018 Feb 10;145:790-804. | ||||
REF 5 | Principal component analysis differentiates the receptor binding profiles of three antipsychotic drug candidates from current antipsychotic drugs. J Med Chem. 2007 Oct 18;50(21):5103-8. | ||||
REF 6 | Selective optimization of side activities: another way for drug discovery. J Med Chem. 2004 Mar 11;47(6):1303-14. | ||||
REF 7 | Identification of a butyrophenone analog as a potential atypical antipsychotic agent: 4-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one. Bioorg Med Chem. 2008 Aug 1;16(15):7291-301. | ||||
REF 8 | Discovery of novel alpha7 nicotinic acetylcholine receptor ligands via pharmacophoric and docking studies of benzylidene anabaseine analogs. Bioorg Med Chem Lett. 2012 Jan 15;22(2):1179-86. | ||||
REF 9 | Support vector machines classification of hERG liabilities based on atom types. Bioorg Med Chem. 2008 Jun 1;16(11):6252-60. | ||||
REF 10 | (+)-Laburnamine, a natural selective ligand and partial agonist for the alpha42 nicotinic receptor subtype. J Nat Prod. 2013 Apr 26;76(4):727-31. | ||||
REF 11 | Discovery and development of alpha7 nicotinic acetylcholine receptor modulators. J Med Chem. 2011 Dec 8;54(23):7943-61. | ||||
REF 12 | Halogenated and isosteric cytisine derivatives with increased affinity and functional activity at nicotinic acetylcholine receptors. Bioorg Med Chem Lett. 2005 Feb 15;15(4):1221-4. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.